tirzepatide: Tirzepatide vs. Semaglutide: What You Should Know Is Tirzepatide Safe? Myths vs.

Gastrointestinal side effects are the most common adverse reactions, particularly during dose escalation

Ji L, Dong X, Li Y et al (2021) Efficacy and safety of once-weekly semaglutide versus once-daily sitagliptin as add-on to metformin in patients with type 2 diabetes in SUSTAIN China: a 30-week, double-blind, phase 3a, randomized trial

He is a member of the International Food Information CouncilAssembly, The Obesity SocietyPresident 2024, American Diabetes Association, Society of Behavioural Medicine, Roundtable on Obesity Solutions, American Society for Nutrition and American Society for Nutrition FoundationBoard of Trustees Executive Committee

Never touch the rubber stopper with your fingers after swabbing

Minor bleeding is normal and typically stops within seconds

This study program named SURPASS comprises six global, two Japanese, and one Asian-Pacific study ( Table 2 gives an overview of the characteristics and results of the entire SURPASS study program ( Table 2 Overview of the SURPASS clinical trial program with tirzepatide in the therapy of type 2 diabetes